SCHEMBL30403552

SCHEMBL30403552

C[C@@H]1CN(c2cccc(Cl)c2)CCO1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.50
HTR3E A5X5Y0 2/20 0.49
HTR3B O95264 2/20 0.49
HTR3A P46098 2/20 0.49
HTR3D Q70Z44 2/20 0.49
HTR3C Q8WXA8 2/20 0.49
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
ADRB1 P08588 1/20 0.47
CYP3A4 P08684 1/20 0.47
HTR1A P08908 1/20 0.47
CYP2D6 P10635 1/20 0.47
THRB P10828 1/20 0.47
CYP2C9 P11712 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
SLC6A4 P31645 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTR7 P34969 1/20 0.47
HTR2B P41595 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26633119 1.00 NOTUM (0.50) NOTUMHTR3EHTR3BHTR3AHTR3D
SCHEMBL22964535 0.83 ADRA2C (0.50) ALDH1A1MAPTALOX15
SCHEMBL28436985 0.82 DRD2 (0.46) HTR7
SCHEMBL29914669 0.82 DRD2 (0.46) HTR7
SCHEMBL27865440 0.82 DRD2 (0.46) HTR7
SCHEMBL2722663 0.81 HTR3E (0.50) NOTUMHTR3EHTR3BHTR3AHTR3D
SCHEMBL2722659 0.81 HTR3E (0.50) NOTUMHTR3EHTR3BHTR3AHTR3D
SCHEMBL10182584 0.81 HTR3E (0.50) NOTUMHTR3EHTR3BHTR3AHTR3D
SCHEMBL27885782 0.81 ADRB1 (0.51) CYP1A2ADRB1CYP3A4CYP2C9CYP2C19
SCHEMBL24681252 0.80 LMNA (0.52) NOTUMCYP3A4HTR1ALMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116171276-A 3- ((1H-pyrazol-4-yl) methyl) -6'- (phenyl) -2H- [1,2' -bipyridin ] -2-one derivatives and related compounds as GRP139 antagonists in methods of treating E.G. depression 武田药品工业株式会社 2023-05-26 CN disclosed